Research in South Carolina

Clinical Trials: Neurological Disorders

There are more than 2,000 clinical trials listed in the National Institutes of Health database – www.clinicaltrials.gov – for neurological disorders, such as Alzheimer’s disease, brain tumors, chronic pain, epilepsy, headache, multiple sclerosis and Parkinson’s disease.  Of those trials, more than 350 are either recruiting patients or have not yet started recruiting patients.  This information is potentially valuable to patients still seeking effective treatments for one of the many neurological disorders.  It provides a new therapeutic option to

Clinical Trials: Heart Disease and Stroke

There are more than 2,000 clinical trials listed in the National Institutes of Health database – www.clinicaltrials.gov – for heart disease and stroke.  Of those trials, more than 400 are either recruiting patients or have not yet started recruiting patients.  This information is potentially valuable to patients still seeking effective treatments for heart disease or stroke.  It provides a new therapeutic option to discuss with physicians.  For current information about the clinical trials that are recruiting or about to recruit patients, please c

Clinical Trials: Blood Cancers

There are 1,679 clinical trials listed in the National Institutes of Health database --www.clinicaltrials.gov -- for blood cancers.  Of those trials, 484 are either recruiting patients or have not yet started recruiting patients. This information is potentially valuable to patients still seeking effective treatments for leukemia, lymphoma, myeloma or other cancers of the blood. It provides a new therapeutic option to discuss with physicians.

Medicines in Development for Older Americans - Clinical Trial Backgrounder

Clinical Trials Backgrounder: Biologics

Medicines in Development: Neurological Disorders

Read More About Medicines in Development for Neurological Disorders

Neurological disorders—such as epilepsy, multiple sclerosis and Parkinson’s disease—inflict great pain and suffering on patients and their families, and every year costs the U.S. economy billions of dollars. Biopharmaceutical research companies are developing 444 new medicines to prevent and treat neurological disorders.

America’s biopharmaceutical research companies are developing 444 new medicines to prevent and treat neurological disorders, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Nearly 450 Innovative Medicines in Development For Neurological Disorders

WASHINGTON, D.C. (July 30, 2013) – America’s biopharmaceutical research companies are developing 444 new medicines to prevent and treat neurological disorders, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Data Sharing Commitments will Enhance Research and Scientific Knowledge, Advance Patient Care and Improve Public Health

Washington, D.C. and Brussels (July 24, 2013) — The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) today strengthened their long-standing commitment to enhancing public health by endorsing joint “Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers.”

Pages

Subscribe to RSS - Innovation